20 June 2013
Keywords: interneuron, alter, obesity, drug, labeling, change, label
Article | 09 September 1996
Interneuron will change the label on its Redux (dexfenfluramine) antiobesity drug to reflect a much greater risk of primary pulmonary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.